Tag | Content |
---|
EnhancerAtlas ID | HS082-01042 |
Organism | Homo sapiens |
Tissue/cell | HCASMC |
Coordinate | chr1:60143100-60145120 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr1:60144580-60144598 | CAGACCTTCCTTCCTCCC | - | 6.11 | GATA2 | MA0036.3 | chr1:60144340-60144351 | TTCTTATCTTC | + | 6.02 | ONECUT2 | MA0756.1 | chr1:60144102-60144116 | GGAAAATCAATAAA | + | 6.25 | ONECUT3 | MA0757.1 | chr1:60144102-60144116 | GGAAAATCAATAAA | + | 6.72 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_51437 | chr1:60142976-60145130 | Skeletal_Muscle | SE_51991 | chr1:60142971-60145302 | Skeletal_Muscle_Myoblast | SE_63797 | chr1:60142878-60145316 | HSMM |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I059677 | chr1 | 60143487 | 60145290 |
|
Enhancer Sequence | AGATAGGCCA ATTTTGGTAG ACTCAACCAG AGTCACCTCC TTCAGATGCT GGGAAGGCTG 60 GGAAGAATCC AGAGGACCCA GACAGTAGAG GTAGGAAAAA CTTTTATGTG CTTGAGGAGA 120 CAGGGTTTTC ATAGGCCCCT GAATGGATGA TTTTCAGCCG GGGGTAGAGT CCTATACCTT 180 TCTTGGGTGA TACCAATGGA TCCACAGCTG TAGATTTTAC TTGTAGCTTT TGTAGACTCT 240 GTGTATCTCA ATTCTGGGAG AATTTTATCA GGGGAAGGGA GACTGGATGG AATATTCTGG 300 TGGGCCCTTA ATGAAAGATT GGCCAACAAC AAGATCTATT GATATTGCAA ATTTTGAAAC 360 ATGCTGACAA TTCCTAGCTT CCTTCTTTTG TTCTTTTATC CATTCAGATT CTCCTTCTCT 420 TAGTTTGTCT CTGTCTCTCT TCCCTTGTCC TTTCCTGCTC TCTCTCTCCC TTTAGACATC 480 TAAAGTCTTC TTACTATTTC TTTGTCAAAT TCGGATCTCA CAAAGGATAC TGACATAGCC 540 ATTCGTTCAT TCTAAAGAAT ACAATGACTA ATACTATCTT AAAGAGTTGC CCCTCTTTAG 600 AAAGGGTGTT TTCCTTTTAG TAGTTTTCAA AACTGTGTCT TTACTAAAGA GAACAGTCTC 660 CTTGTGGACA AGTATTCTTG AAGGCAAATC ATGATCAGCT TTATATCTGC GGTTTAATGA 720 AAAATATGGA ATCAAGCCAC AGATATGCTG CTCTCACAGT AAAAATTTAG CTATTGAATA 780 AGTGGGAGGG GACACAAAGA AGGCAGTTCA CTTCCCCTCC CTTTACTCTT AGGAATGTGG 840 AATCCCTGCA GTCTTGACCT CTGTGACCTT TCTACTTGAT CCCTCCCCCA TCATCAGTAG 900 AGTACAAAAT GATCCTCTGT AATTCTGAAT ATCTTGGAAA ACAAATAATT ATAATTAGAA 960 GCTGAGAGTG TTCCATAACA CTTCTCTAGG CTCCCAGGTC CTGGAAAATC AATAAACTGG 1020 AAAAAAACTA AGTTTATGAA ATATCACTAT GCTTACACTT TCTAAGCACA GACAGTTAAA 1080 AGATTCTAAG AAATACAAGG ACAAATAAAT AAAACAAGAA GCAGTTTCAA GTCGTTGTGA 1140 GAGAAAACTC AATCAAATGG CAAAGAGACA GCAACATGAA ATGGCTCTCC ACTTTCTGTT 1200 TCCTTCAGGC CCCCTGCAGA TGTCATTAGC TTTCTGTAAT TTCTTATCTT CAGGGGCAGT 1260 TTTTATTCAA GTCTATTTAG ACAAAACAAG CTTTAATTCC AGCAGTGCTA TTTGTCTTGA 1320 ACCACCACCC CCCACCCTTG AAAAAAAGGA GTGGAGGAAG CATCTGAAGC AAAAATCAGT 1380 AAAAGGAGAC AGTGACAAGA GATCAAAATG CATTCAGCAG TCATTTTAAG GGGAGTACCA 1440 GTGTAAAGAA AATAAGCCCT TGGAATCAGC CAATTAATCA CAGACCTTCC TTCCTCCCAC 1500 TGTGTGAGTG TTGCCACCCC TGTAAACCAC TGACTCCATG CACTCTCACC ATCAACTTTC 1560 CCTGTCACGT TCCAGACAGA CTCCTGTGTC TTCAAGACCA ATACATGTAA GTGGCCAGTT 1620 GAGAGCTGTG ATTACTCACC CTTTCTGTAA TGTGTGCCCA CAAGATAAAC CATCCATGCT 1680 GACCGCAGTG GTCTACCCTT GAGGTCATTC CTTGCAAACA TCCTCATTGC TTAGCTGAAA 1740 CCTCTACTTC TGTTCTTTTT CATGAAATTC ACTTCATTTA GGGCCAGTTA TACTCATCAC 1800 CTGTTATGCA TTTCAGAGCC TATGATTTTT GTATATAACA TGTCTCCCAT TCTATTTTAT 1860 TTTGTAAGAG TCAACTTTCT GTGATTTTTT TTTTTAGCTC TATTTGGCTT TCTGTCACGA 1920 TAAATAACAG TTTTGCTATT TGCAAAATAA AGCTGATTAT CATTATTTTA GTTTCCAGAG 1980 GTTAGAAAAA ACTGAAATAC CGTAGATGTT CAGAAGTATG 2020
|